Email Updates

You are here

Experimental mRNA-based Preventive HIV Vaccine Phase 1 Trials

top

AVAC
March 2022
General

The NIH announced a new study to test three mRNA-based HIV vaccine candidates. This study follows an announcement in January from IAVI about another mRNA-based HIV vaccine study. This snapshot compares the two studies.